Your Health: New Alzheimer's Drug

In this Your Health segment, Paul Fishman, MD, PhD, discusses a new medication to treat Alzheimer's disease, Leqembi (lecanemab-irmb), recently approved by the U.S. Food and Drug Administration. Dr. Fishman is a neurologist at the University of Maryland Medical Center and a professor of neurology at the University of Maryland School of Medicine. For more information call 410-328-4323 Learn more: https://www.umms.org/ummc/health-serv...